| Dr Alton Earl Moore Ii, DO | |
|
18951 N Memorial Dr, Ste 153, Humble, TX 77338-4217 | |
| (281) 319-8409 | |
| (281) 540-7109 |
| Full Name | Dr Alton Earl Moore Ii |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 17 Years |
| Location | 18951 N Memorial Dr, Humble, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235458076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | N5259 (Texas) | Secondary |
| 208M00000X | Hospitalist | N5259 (Texas) | Secondary |
| 207Q00000X | Family Medicine | N5259 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Northeast Hospital | Humble, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
A clinical study - known as IRONMAN - will determine if iron supplement injections could ease the disabling symptoms of heart failure. The trial was officially launched today at the British Cardiovascular Society Conference in Manchester.
Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.
Combining dose-volume histogram parameters with age and baseline pulmonary fibrosis score creates a novel predictive risk score that improves prediction of radiation pneumonitis in patients receiving concurrent chemoradiotherapy for non-small-cell lung cancer, research shows.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.
› Verified 3 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
A clinical study - known as IRONMAN - will determine if iron supplement injections could ease the disabling symptoms of heart failure. The trial was officially launched today at the British Cardiovascular Society Conference in Manchester.
Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.
Combining dose-volume histogram parameters with age and baseline pulmonary fibrosis score creates a novel predictive risk score that improves prediction of radiation pneumonitis in patients receiving concurrent chemoradiotherapy for non-small-cell lung cancer, research shows.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
A clinical study - known as IRONMAN - will determine if iron supplement injections could ease the disabling symptoms of heart failure. The trial was officially launched today at the British Cardiovascular Society Conference in Manchester.
Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.
Combining dose-volume histogram parameters with age and baseline pulmonary fibrosis score creates a novel predictive risk score that improves prediction of radiation pneumonitis in patients receiving concurrent chemoradiotherapy for non-small-cell lung cancer, research shows.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas - Humble, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376021998 PECOS PAC ID: 9931451838 Enrollment ID: O20181003003196 |
News Archive
A clinical study - known as IRONMAN - will determine if iron supplement injections could ease the disabling symptoms of heart failure. The trial was officially launched today at the British Cardiovascular Society Conference in Manchester.
Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.
Combining dose-volume histogram parameters with age and baseline pulmonary fibrosis score creates a novel predictive risk score that improves prediction of radiation pneumonitis in patients receiving concurrent chemoradiotherapy for non-small-cell lung cancer, research shows.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alton Earl Moore Ii, DO 18951 N Memorial Dr, Ste 153, Humble, TX 77338-4217 Ph: (281) 319-8409 | Dr Alton Earl Moore Ii, DO 18951 N Memorial Dr, Ste 153, Humble, TX 77338-4217 Ph: (281) 319-8409 |
News Archive
A clinical study - known as IRONMAN - will determine if iron supplement injections could ease the disabling symptoms of heart failure. The trial was officially launched today at the British Cardiovascular Society Conference in Manchester.
Dariush Mozzaffarian and Meir J Stamper, wrote an article in the British Medical Journal urging the government to ban industrial trans fatty acids or TFAs. This adds to the plea of doctors and medical charities across the country, who want to follow the example of Denmark and New York City where TFAs have been eradicated without affecting the price, taste or availability of products.
Combining dose-volume histogram parameters with age and baseline pulmonary fibrosis score creates a novel predictive risk score that improves prediction of radiation pneumonitis in patients receiving concurrent chemoradiotherapy for non-small-cell lung cancer, research shows.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.
› Verified 3 days ago
Michael Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18951 N Memorial Dr, Humble, TX 77338 Phone: 128-154-0770 | |
Ankur Pradhan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18951 N Memorial Dr Ste 103w, Humble, TX 77338 Phone: 281-540-8409 | |
Alice M. Ramos, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 19411 Mckay Dr Ste 150, Humble, TX 77338 Phone: 281-459-9181 | |
Dr. Madeline Anderson Hunt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8233 N Sam Houston Pkwy E, Humble, TX 77396 Phone: 713-442-2000 | |
Dr. Harish K Pariani, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 20114 Atascocita Shores Dr, Humble, TX 77346 Phone: 281-852-2676 Fax: 832-228-8236 | |
Khilan Pindoria, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18951 N Memorial Dr, Humble, TX 77338 Phone: 281-540-7700 | |
Dr. Rekha S. Neela, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18951 N Memorial Dr Ste 103w, Humble, TX 77338 Phone: 281-540-8409 |